Simple test an early predictor of Alzheimer’s

brain

A new inexpensive and simple test can screen for mild cognitive impairment (MCI), a condition that affects language, memory, and related mental functions that is distinct from ordinary mental degradation associated with aging and is a likely precursor to the more serious Alzheimer’s disease. MRI—magnetic resonance imaging—is the most reliable and direct way to diagnose MCI. But for many, the procedure is unavailable or too expensive, says Michael Wenger. Credit: Courtesy iStockphoto

PENN STATE (US)—An inexpensive and easy test has been developed to test the brain’s capacity for information—a reliable predictor of Alzheimer’s disease.

“We have developed a low-cost behavioral assessment that can clue someone in to Alzheimer’s disease at its earliest stage,” says Michael Wenger, associate professor of psychology at Penn State.

“By examining (information) processing capacity, we can detect changes in the progression of mild cognitive impairment (MCI).”

MCI, a condition that affects language, memory, and related mental functions, is distinct from the ordinary mental degradation associated with aging and is a likely precursor to the more serious Alzheimer’s disease.

Both MCI and Alzheimer’s are linked to a steady decline in the volume of the hippocampus, the area of the brain responsible for long term memory and spatial reasoning.

MRI—magnetic resonance imaging—is the most reliable and direct way to detect hippocampal atrophy and diagnose MCI. But for many, the procedure is unavailable or too expensive.

“MRIs can cost hundreds of dollars an hour,” Wenger says. “We created a much cheaper alternative, based on a memory test, that correlates with hippocampal degradation.”

Details of the findings are published in the Journal of Mathematical Psychology.

From a computer model of an atrophying hippocampus, the researchers determined how to estimate capacity with a statistical measure of how quickly tasks are completed.

Applying this analysis to a memory test for people with MCI, the researchers were able to gauge their hippocampal capacity and compare it to the progression of their ailment.

“These capacity measures we developed showed a reliable relationship to the hippocampal volume measurements, so we know we are on the right track,” says Wenger.

The scientists began by modeling the hippocampus as a complex electrical circuit. Equations governing electric current and voltage mimicked the electrical firing of neurons within the circuit. In the simulation, neurons were switched off to model atrophy of the hippocampus.

With fewer cells available to process electrical signals, the model hippocampus slowed down, but its capacity for processing information decreased at an even faster rate. Capacity was the most sensitive measure of how the hippocampus was deteriorating, more than the average processing speed.

“We then applied this to the gold standard of the field — the Free and Cued Selective Reminding Test (FCSRT),” Wenger explains. “This is a test that can discriminate between normal age-related memory changes and changes caused by impairment.”

The test was given to five groups of participants: college students, healthy middle-aged adults, healthy elderly individuals, people with diagnosed cases of MCI, and a control group of age-matched individuals without MCI. The first three groups each had 100 members and the last two each had 50.

Participants were shown descriptive words, such as “part of the body” and “artery” and asked to choose the picture that fit the cues from a set of 24 images, in this case, a picture of a heart.

They were then asked to recall as many items as they could. For objects they failed to remember, the psychologists provided the category cues, providing more information and testing the limits of the subjects’ capacity.

The researchers analyzed the response times for the tasks and the number of items that were recalled, with and without additional cues.

The MCI group showed the greatest sensitivity to added cues—the additional input either substantially helped or inhibited their performance. But like the computer model, estimates of capacity highlighted the greatest cognitive difference between the MCI group and the others.

The study’s approach to defining processing capacity is unusual. The scientists combined disparate principles of engineering and statistics, mathematically translating processing capacity into what is called the “hazard function.”

The hazard function is well known in engineering, but relatively new for fields like psychology. It gives the probability that a task that is not yet completed will be completed in the next interval of time.

By measuring how long it takes a participant to recall the objects during the FCSRT, the psychologists fit a model based on the hazard function to each participant and obtain a measure of his or her capacity for the memorization task.

The difference in hazard function measures between the MCI group and all other groups was statistically much more pronounced than the differences between all groups in the number of items they recalled.

These hazard function differences also outweighed the contrasts between all groups in their response times. The hazard function model proved to be the most sensitive diagnostic for cognitive distinctions in the groups, making it a reliable indicator of capacity and a better signal of the underlying hippocampal atrophy than processing speed alone.

The test can track the progression of MCI for anyone, anywhere as long as there is access to a computer because it relies on personal reaction times, hazard analysis, and performance.

“These results are still preliminary, but very encouraging,” Wenger says. “We plan to study what this approach can tell us about mental impairments related to other conditions, like iron deficiencies, in the future.”

The National Institute on Aging provided funding for this project.

Penn State news: http://live.psu.edu/

chat4 Comments

You are free to share this article under the Creative Commons Attribution-NoDerivs 3.0 Unported license.

4 Comments

  1. J Hayes

    So how many $billions a year could this save? But will the “for profit medical business” let it happen?

  2. Bill Martin

    Where is this test available? What is the NAME of this test?

    I have a 93 year old mother. I’d like to get her tested, as well as take the test myself at age 72.

  3. Michael Wenger

    The timed version of this test has only been used in research studies, to my knowledge. However, the FCSRT has been used quite widely, and for a number of years. The Mayo Alzheimer’s Disease Research Center would be a good place to start for more information:

    http://mayoresearch.mayo.edu/mayo/research/alzheimers_center/contact.cfm

    -Michael Wenger

  4. E Gibbons

    Given that we undergo mamograms, pap smears, colonoscopy at prescribed ages and have our blood pressure, cholesterol, etc., checked routinely to see where we are at, it would be great to have access to a FCSRT at age 50 to 60. Would be nice to do online in the privacy of one’s own home – notify your doc that you need further checking if you don’t perform well. Could give many future AD victims a heads up for ‘end of sanity’ preparations.

We respect your privacy.